Galena Biopharma Inc $2.31

down -0.02


20/8/2014 10:27 AM  |  NASDAQ : GALE  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get GALE Trend Analysis - it has outperformed the S&P 500 by 2%

Partner Headlines

  1. Morning Market Losers

    Benzinga
  2. Intercept Pharma Soars On Positive Liver Drug Data

    IBD
  3. Markets Open Higher; McDonald's Profit Misses Estimates

    Benzinga
  4. Top Healthcare Movers For June 9, 2014

    Benzinga
  5. Mid-Morning Market Update: Markets Open Higher; Forest Labs To Acquire ...

    Benzinga
  6. Morning Market Movers

    Benzinga
  7. Galena Biopharma Announces Department of Defense Grant for NeuVax Clinical ...

    Benzinga
  8. Morning Market Losers

    Benzinga
  9. After-Hours Movers for Mar. 17, 2014: FF, GALE Higher, OXBT, EOX, TWER, ...

    Benzinga
  10. Earnings Scheduled For March 17, 2014

    Benzinga
  11. Mid-Afternoon Market Update: 3D Printing Names Take a Hit From Barron's ...

    Benzinga
  12. Mid-Day Market Update: Chiquita Gains On Merger News; Cliffs Natural Shares ...

    Benzinga
  13. Mid-Morning Market Update: Markets Open Lower; McDonald's Comparable Sales ...

    Benzinga
  14. Mornings Movers for Feb. 28, 2014: CETV, OTVI, MELI, REGI, GALE Moving ...

    Benzinga
  15. UPDATE: Cantor Fitzgerald Downgrades Galena Biopharma

    Benzinga
  16. Sector Gainers And Losers For The Week Ending February 14, 2014

    Benzinga
  17. Morning Market Losers

    Benzinga
  18. Market Wrap For January 17: Stocks Finish Week With Mixed Results

    Benzinga
  19. Top Trending Tickers On StockTwits For January 17

    Benzinga
  20. Galena Biopharma Acquires Mills Pharmaceuticals

    Benzinga
  21. Galena Enrolls First Patient in GALE-301 Cancer Immunotherapy Phase 2 Clinical ...

    Benzinga
  22. UPDATE: Oppenheimer Initiates Coverage on Galena Biopharma on NeuVax/Abstral ...

    Benzinga
  23. Benzinga's Top Initiations

    Benzinga
  24. Galena Biopharma Announces Phase 1 Trial Showa Folate Binding Protein Vaccine ...

    Benzinga
  25. Galena Biopharma Launches Abstral Sublingual Tablets for Treatment of Breakthrough ...

    Benzinga
  26. Galena Begins RELIEF Patient Registry for Abstral Sublingual Tablets

    Benzinga
  27. Benzinga's Top Initiations

    Benzinga
  28. UPDATE: Piper Jaffray Initiates Galena Biopharma at Overweight on ImmunoRx ...

    Benzinga
  29. Mid-Day Market Update: Markets Rising, Gun Stocks Feel the Heat

    Benzinga
  30. Mid-Morning Market Update: Markets Rise, Firearm Stocks Take a Beating

    Benzinga
  31. Morning Market Losers

    Benzinga
  32. Galena Biopharma, Leica Biosystems Partner on Development of Companion ...

    Benzinga
  33. Morning Market Movers

    Benzinga
  34. Galena Biopharma Announces Partnership with Teva

    Benzinga
  35. Galena Biopharma Announces Signature of Commercialization Partnership With ...

    Benzinga
  36. UPDATE: Aegis Capital Corp. Initiates Coverage on Galena Biopharma with ...

    Benzinga
  37. UPDATE: Dawson James Initiates Galena Biopharma at Market Outperform

    Benzinga
  38. Galena Biopharma Reports Data Demonstrate Role of NeuVax in Preventing ...

    Benzinga
  39. UPDATE: McNicoll Lewis Vlak Initiates Galena Biopharma at Buy on Cancer ...

    Benzinga
  40. WellPoint, Iron Mountain Incorporated Among Stocks Up on High Volume Wednesday

    FoxBusiness
  41. Cantor Fitzgerald Reiterates Buy Rating, $4 PT on Galena Biopharma

    Benzinga
  42. Galena Biopharma Issued Folate Binding Protein Cancer Vaccine Patent in ...

    Benzinga
  43. Skin scarring research

    IBD
  44. Benzinga's Microcap Movers for Tuesday June 19, 2012

    Benzinga
  45. Cantor Fitzgerald Initiates Coverage of Galena Biopharma with Buy Rating, ...

    Benzinga
  46. Galena Biopharma Presents NeuVax Phase 1/2 Boosters Improve Disease-Free ...

    Benzinga
  47. Veeco Instruments, Sourcefire Among Stocks Gapping Up Tuesday

    FoxBusiness
  48. Galena Biopharma Establishes Record Date for Spin-Off Stock Dividend of ...

    Benzinga
  49. Galena Biopharma Initiates Enrollment in Phase 1/2 Trial for Folate Binding ...

    Benzinga
Trading Center